Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - REVENUE
Revenue ADAP - Adaptimmune Therapeutics plc
60.3 M
LAST VALUE
213.10%
2 YEAR CAGR
0.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR